Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Olga S. Epifanovskaya"'
Autor:
Sergei V. Raik, Tatiana V. Mashel, Albert R. Muslimov, Olga S. Epifanovskaya, Mikhail A. Trofimov, Daria N. Poshina, Kirill V. Lepik, Yury A. Skorik
Publikováno v:
Materials, Vol 14, Iss 9, p 2467 (2021)
Polyplex-based gene delivery systems are promising substitutes for viral vectors because of their high versatility and lack of disadvantages commonly encountered with viruses. In this work, we studied the DNA polyplexes with N-[4-(N,N,N-trimethylammo
Externí odkaz:
https://doaj.org/article/0c661fff5aca4b82b2958f1ad930a7da
Autor:
Oleksii O. Peltek, Eduard I. Ageev, Pavel M. Talianov, Anna D. Mikushina, Olga S. Epifanovskaya, Aliaksei Dubavik, Vadim P. Veiko, Kirill Lepik, Dmitry A. Zuev, Alexander S. Timin, Mikhail V. Zyuzin
Publikováno v:
Nanophotonics. 11:4323-4335
Photothermal therapy (PTT) has attracted increasing interest as a complementary method to be used alongside conventional therapies. Despite a great number of studies in this field, only a few have explored how temperatures affect the outcome of the P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5570f37d3206457029e4a7a940d126d9
https://doi.org/10.1515/nanoph-2022-0314
https://doi.org/10.1515/nanoph-2022-0314
Autor:
Alexandr L Alyanskii, Elena V. Babenko, Inna V. Markova, OV Pirogova, Evgeny A. Bakin, Anna A Dotcenko, Sergey N. Bondarenko, Boris V. Afanasyev, Sergey V. Lapin, Vladislav S. Sergeev, Olga S. Epifanovskaya, Ivan S. Moiseev, Alla A Golovacheva, Elena Surkova, Elena I. Darskaya, Elena V. Morozova, Daria A Kuznetsova
Publikováno v:
Bone Marrow Transplantation. 55:544-552
The predictive value of graft composition and plasma biomarkers on the outcome of allogeneic HSCT is well known for conventional GVHD prophylaxis based on calcineurin inhibitors with or without antithymocyte globulin. Currently, there is limited data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d7166360ba988c313450d4d9c36c556
https://doi.org/10.1038/s41409-019-0665-3
https://doi.org/10.1038/s41409-019-0665-3
Autor:
Olga S. Epifanovskaya, M. V. Zhukov, Gleb B. Sukhorukov, Alena I. Shakirova, Timofey E. Karpov, Boris V. Afanasyev, Albert R. Muslimov, Kirill V. Lepik, Yana V. Tarakanchikova, Alexander S. Timin, Mikhail V. Zyuzin, Vladislav S. Sergeev, Oleksii O. Peltek
Publikováno v:
ACS Applied Materials & Interfaces. 11:13091-13104
An important area in modern malignant tumor therapy is the optimization of antitumor drugs pharmacokinetics. The use of some antitumor drugs is limited in clinical practice due to their high toxicity. Therefore, the strategy for optimizing the drug p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3581db79fd7b391ef1399e6d6ea1bca7
https://doi.org/10.1021/acsami.8b22685
https://doi.org/10.1021/acsami.8b22685
Autor:
Olga S. Epifanovskaya, Yury A. Skorik, Albert R. Muslimov, Kirill V. Lepik, Daria N. Poshina, Mikhail A. Trofimov, Sergei V. Raik, Tatiana V. Mashel
Publikováno v:
Materials, Vol 14, Iss 2467, p 2467 (2021)
Materials
Volume 14
Issue 9
Materials
Volume 14
Issue 9
Polyplex-based gene delivery systems are promising substitutes for viral vectors because of their high versatility and lack of disadvantages commonly encountered with viruses. In this work, we studied the DNA polyplexes with N-[4-(N,N,N-trimethylammo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32cabe3023cf38fba9134fff48a2708e
https://www.mdpi.com/1996-1944/14/9/2467
https://www.mdpi.com/1996-1944/14/9/2467
Autor:
Elena Surkova, Sergey N. Bondarenko, Olga S. Epifanovskaya, Olga V. Kudyasheva, A. Beynarovich, Valentina V. Porunova, Sergey Lapin, Anna V. Botina, Varvara N. Ovechkina, Oleg Golosgchapov, Olesya Smikova, Vadim Baykov, OV Pirogova, Ivan S. Moiseev, Elena V. Morozova, Yulia Vlasova, Anna Dotsenko, Elena V. Babenko, E. Borzenkova, Tatyana Rudakova, Mikhail M Kanunnikov, Boris Afansyev, Anna G. Smirnova
Publikováno v:
Transplantation and cellular therapy. 27(7)
The prognosis of acute leukemia refractory to induction chemotherapy or immunotherapy is dismal. Salvage allogeneic hematopoietic stem cell transplantation (HSCT) is widely used option for these patients, but only 10% to 15% of patients are cured by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::497471001ce2f723774e7079712314fb
https://pubmed.ncbi.nlm.nih.gov/33845259
https://pubmed.ncbi.nlm.nih.gov/33845259
Autor:
Boris V. Afanasyev, Olga S. Epifanovskaya, Yulia V. Rudnitskaya, Elena V. Morozova, Nikolay U. Tcvetkov, Ivan S. Moiseev
Publikováno v:
Cellular Therapy and Transplantation. 7:44-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99396e89d46aee453b9be92c6f4cad15
https://doi.org/10.18620/ctt-1866-8836-2018-7-1-44-51
https://doi.org/10.18620/ctt-1866-8836-2018-7-1-44-51
Autor:
Olga S. Epifanovskaya, Kristoffer Riecken, Boris V. Afanasyev, Kirill V. Lepik, Gleb B. Sukhorukov, Alexander S. Timin, Ulrike Mock, Albert R. Muslimov, Vladislav S. Sergeev, Alena I. Shakirova, Maria V. Okilova, Boris Fehse
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 14:97-108
CRISPR-Cas9 is a revolutionary genome-editing technology that has enormous potential for the treatment of genetic diseases. However, the lack of efficient and safe, non-viral delivery systems has hindered its clinical application. Here, we report on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704f0c56529e3af6a7458cad01e40950
https://doi.org/10.1016/j.nano.2017.09.001
https://doi.org/10.1016/j.nano.2017.09.001
Autor:
Alexander S. Timin, Aleksandra V. Petrova, Boris Fehse, A. N. Gorshkov, Boris V. Afanasyev, Albert R. Muslimov, Gleb B. Sukhorukov, Andrey V. Vasin, Kirill V. Lepik, Eugenia V. Il’inskaja, Olga S. Epifanovskaya, Alena I. Shakirova
Publikováno v:
ACS Biomaterials Science & Engineering. 3:2314-2324
Stem cell engineering-the manipulation and functionalization of stem cells involving genetic modification-can significantly expand their applicability for cell therapy in humans. Toward this aim, reliable, standardized, and cost-effective methods for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e20ebc3289d149043e46e7d44b33317b
https://doi.org/10.1021/acsbiomaterials.7b00482
https://doi.org/10.1021/acsbiomaterials.7b00482
Autor:
Julia J. Vlasova, Elena V. Morozova, Maria V. Barabanshikova, Kirill V. Lepik, Ivan S. Moiseev, Axel R. Zander, Elena V. Babenko, Anna G. Smirnova, Eugene A. Bakin, Olga S. Epifanovskaya, Nikolai Yu. Tcvetkov
Publikováno v:
Blood. 136:43-44
Background Immune checkpoint (IC) inhibitors (ICI) is a promising group of agents with potential effect in myelodysplastic syndrome (MDS). However, there is not enough data on the pattern of IC expression in MDS bone marrow, though this can guide fut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05f9774d8c79823275de5e60c52a2eef
https://doi.org/10.1182/blood-2020-141997
https://doi.org/10.1182/blood-2020-141997